Pathogenic characterization of a cervical lymph node derived from a patient with Kawasaki disease.
暂无分享,去创建一个
T. Mizutani | M. Saijo | S. Morikawa | Yuko Sato | H. Hasegawa | H. Katano | M. Kuroda | T. Sekizuka | Seiichi Sato | Hitomi Fukumoto | Akiko Kinumaki
[1] T. Sata,et al. A novel real‐time PCR system for simultaneous detection of human viruses in clinical samples from patients with uncertain diagnoses , 2010, Journal of medical virology.
[2] Nicholas J Loman,et al. High-throughput sequencing and clinical microbiology: progress, opportunities and challenges. , 2010, Current opinion in microbiology.
[3] R. Yeung. Kawasaki disease: update on pathogenesis , 2010, Current opinion in rheumatology.
[4] Yusuke Nakamura,et al. Common variants in CASP3 confer susceptibility to Kawasaki disease. , 2010, Human molecular genetics.
[5] K. Kotani,et al. Epidemiologic Features of Kawasaki Disease in Japan: Results of the 2007–2008 Nationwide Survey , 2010, Journal of epidemiology.
[6] S. Israels,et al. Mechanisms of oral bacteria-induced platelet activation. , 2010, Canadian journal of physiology and pharmacology.
[7] Masato Tashiro,et al. Characterization of Quasispecies of Pandemic 2009 Influenza A Virus (A/H1N1/2009) by De Novo Sequencing Using a Next-Generation DNA Sequencer , 2010, PloS one.
[8] Teruyo Ito,et al. Heat shock proteins and superantigenic properties of bacteria from the gastrointestinal tract of patients with Kawasaki disease , 2009, Immunology.
[9] Forest Rohwer,et al. Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals , 2009, PloS one.
[10] S. Hammerschmidt,et al. Pneumococcal association to platelets is mediated by soluble fibrin and supported by thrombospondin-1 , 2009, Thrombosis and Haemostasis.
[11] N. Yoshikawa,et al. Detection of multiple superantigen genes in stools of patients with Kawasaki disease. , 2009, The Journal of pediatrics.
[12] K. Durongpisitkul,et al. Clinical manifestations of Kawasaki disease: what are the significant parameters? , 2009, Asian Pacific journal of allergy and immunology.
[13] J. Kawai,et al. Direct Metagenomic Detection of Viral Pathogens in Nasal and Fecal Specimens Using an Unbiased High-Throughput Sequencing Approach , 2009, PloS one.
[14] E. Charpentier,et al. Lysogenic transfer of group A Streptococcus superantigen gene among Streptococci. , 2008, The Journal of infectious diseases.
[15] T. Fukaya,et al. The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease , 2007, Current opinion in infectious diseases.
[16] Alexander F. Auch,et al. MEGAN analysis of metagenomic data. , 2007, Genome research.
[17] J. Petrik,et al. Progression towards AIDS leads to increased torque teno virus and torque teno minivirus titers in tissues of HIV infected individuals , 2007, Journal of medical virology.
[18] R. Yeung,et al. TNF-α Is Necessary for Induction of Coronary Artery Inflammation and Aneurysm Formation in an Animal Model of Kawasaki Disease1 , 2006, The Journal of Immunology.
[19] Walter R Wilson,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Pediatrics.
[20] N. Ohno. Murine model of Kawasaki disease induced by mannoprotein-beta-glucan complex, CAWS, obtained from Candida albicans. , 2004, Japanese journal of infectious diseases.
[21] Kazuo Suzuki,et al. Induction of Coronary Arteritis with Administration of CAWS (Candida albicans Water‐Soluble Fraction) Depending on Mouse Strains , 2004, Immunopharmacology and immunotoxicology.
[22] W. Yeo,et al. Gross Elevation of TT Virus Genome Load in the Peripheral Blood Mononuclear Cells of Cancer Patients , 2001, Annals of the New York Academy of Sciences.
[23] K. Katayama,et al. Changes of DNA titer and sequence variance of TT virus in hepatic disorders. , 2001, Hepatology research : the official journal of the Japan Society of Hepatology.
[24] T. Sata,et al. Progressive outer retinal necrosis caused by herpes simplex virus type 1 in a patient with acquired immunodeficiency syndrome. , 2000, Ophthalmology.
[25] N. Horiike,et al. Existence of TT Virus DNA in Extracellular Body Fluids from Normal Healthy Japanese Subjects , 2000, Intervirology.
[26] S. Mori,et al. High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma. , 1999, The American journal of pathology.
[27] Y. Liaw,et al. High Prevalence of TT Virus Infection in Healthy Children and Adults and in Patients with Liver Disease in Taiwan , 1999, Journal of Clinical Microbiology.
[28] Mark George Thomas,et al. Presence of a newly described human DNA virus (TTV) in patients with liver disease , 1998, The Lancet.
[29] T. Nishizawa,et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. , 1997, Biochemical and biophysical research communications.
[30] K. Waki,et al. A case of Kawasaki disease with coronary artery aneurysms documenting Yersinia pseudotuberculosis infection , 1997, Acta paediatrica.
[31] Y. Ito,et al. Clinical role for a superantigen in Yersinia pseudotuberculosis infection. , 1997, The Journal of clinical investigation.
[32] S. Shulman,et al. Seven‐year national survey of Kawasaki disease and acute rheumatic fever , 1994, The Pediatric infectious disease journal.
[33] T. Ezaki,et al. Biologically active extracellular products of oral viridans streptococci and the aetiology of Kawasaki disease. , 1993, Journal of medical microbiology.
[34] M. Herzberg,et al. The Streptococcus sanguis platelet aggregation-associated protein. Identification and characterization of the minimal platelet-interactive domain. , 1993, The Journal of biological chemistry.
[35] T. Sata,et al. Detection of capsid antigen of human papillomavirus (HPV) in benign lesions of female genital tract using anti‐HPV monoclonal antibody , 1992, The Journal of pathology.
[36] S. Matsumoto,et al. Kawasaki Disease and Epstein‐Barr Virus , 1991, Lancet.
[37] C. Benoist,et al. Superantigens interact with MHC class II molecules outside of the antigen groove , 1990, Cell.
[38] P. Marrack,et al. Residues of the variable region of the T-cell-receptor β-chain that interact with S. aureus toxin superantigens , 1990, Nature.
[39] P. Marrack,et al. V beta-specific stimulation of human T cells by staphylococcal toxins. , 1989, Science.
[40] J. Fraser. High-affinity binding of staphylococcal enterotoxins A and B to HLA-DR , 1989, Nature.
[41] Philippa Marrack,et al. The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice , 1989, Cell.
[42] J. Steitz,et al. Localization of Epstein-Barr virus-encoded small RNAs by in situ hybridization. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[43] P. Krause,et al. Lymph node biopsy for early diagnosis in Kawasaki disease , 1982, The American journal of surgical pathology.
[44] M. Bergdoll,et al. A NEW STAPHYLOCOCCAL ENTEROTOXIN, ENTEROTOXIN F, ASSOCIATED WITH TOXIC-SHOCK-SYNDROME STAPHYLOCOCCUS AUREUS ISOLATES , 1981, The Lancet.
[45] T. Kawasaki,et al. [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].
[46] Hong Qiang,et al. Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis , 2010, Journal of clinical laboratory analysis.
[47] 中村 常之. Vasculitis induced by immunization with bacillus Calmette-Guerin followed by atypical mycobacterium antigen : a new mouse model for Kawasaki disease , 2007 .
[48] T. Sata,et al. Immunohistochemical study of skin lesions in herpes zoster , 2005, Virchows Archiv A.
[49] T. Sata,et al. A comparative study of congenital and postnatally acquired human cytomegalovirus infection in infants: lack of expression of viral immediate early protein in congenital cases , 2004, Virchows Archiv.
[50] E. Silverman,et al. Superantigenic activity is responsible for induction of coronary arteritis in mice: an animal model of Kawasaki disease. , 2003, International immunology.
[51] K. Pfizenmaier,et al. N-glycosidase treatment of Colo 205 cells interferes with hIFN-gamma induced HLA-DR expression. , 1989, Lymphokine research.